Shares of Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $3.30, but opened at $3.00. Curaleaf shares last traded at $3.09, with a volume of 342,619 shares traded.
Analyst Upgrades and Downgrades
Separately, Cormark raised shares of Curaleaf from a “hold” rating to a “moderate buy” rating in a research report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, According to MarketBeat.com, the stock presently has an average rating of “Strong Buy”.
Read Our Latest Stock Analysis on Curaleaf
Curaleaf Trading Down 9.8%
Curaleaf (OTCMKTS:CURLF – Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%. As a group, analysts expect that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.
About Curaleaf
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Read More
- Five stocks we like better than Curaleaf
- Canada Bond Market Holiday: How to Invest and Trade
- Kohl’s Stock Rebound Faces a Showdown With Short Sellers
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- 3 Heavily Shorted Stocks That Could Prove the Bears Wrong
- How to Calculate Return on Investment (ROI)
- Is Fund Flow Hype Real? 3 ETFs With Big Inflows in the Last Month
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.